Avizen Biopharma Private Limited - Company Profile

It is a pharma private limited company based in Guwahati, Assam, India, established in 2016.
2016 Guwahati, Assam, India Active
Last Updated:
Access Report
About Avizen Biopharma Private Limited

Avizen Biopharma Private Limited, a active private limited company, was established on 09 August 2016 in Guwahati, Assam, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24304AS2016PTC017532. Registered under ROC Roc Guwahati. it is unlisted. It has an authorized capital of ₹5.50 Cr and a paid-up capital of ₹5.42 Cr.

It upholds a compliant status. Employing 13 professional, Its leadership includes Rajendra Kumar Verma (Director), Mahendra Kumar Verma (Director), Sunil Kumar Khemani (Director). Past directors included Rajendra Kumar Verma, Subhkaran Verma, Sunil Kumar Khemani. It holds ₹6.10 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sagar Bizz Plex, 1St Floor S.R. Bora Lane, G.S. Road, Ulubari, Guwahati, Assam, 781007.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24304AS2016PTC017532

  • Registration Number

    017532

  • Incorporation Date

    09 August 2016

  • Authorized Capital

    ₹5.50 Cr

  • Paid-Up Capital

    ₹5.42 Cr

  • ROC Code

    Roc Guwahati

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.50 Cr
  • Paid Up Capital ₹ 5.42 Cr
  • Company Age 9 Year, 6 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 6.10 Cr
  • Revenue Growth **** 43.52%
  • Profit Growth **** 55.49%
  • Ebitda **** -243.48%
  • Net Worth -84.43%
  • Total Assets **** 11.74%
Company report

Avizen Biopharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Avizen Biopharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Avizen Biopharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Rajendra Kumar Verma Director 09 Aug 2016 Current
Mahendra Kumar Verma Director 09 Aug 2016 Current
Sunil Kumar Khemani Director 25 Feb 2017 Current
Alka Verma Director 17 Jul 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 06 Jul 2022 Past
Pramod Abcsdd Additional Director 19 Jul 2025 Past
Pramod Abcsdd Additional Director 14 Dec 2017 Past
Pramod Abcsdd Director 19 Oct 2016 Past
Pramod Abcsdd Additional Director 29 Sep 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Avizen Biopharma.

Avizen Biopharma Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 43.52% increase. The company also saw a substantial improvement in profitability, with a 55.49% increase in profit. The company's net worth observed a substantial decline by a decrease of 84.43%.

Avizen Biopharma revenue growth over time
Avizen Biopharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 43.52%
*******
*******
*******
*******
Revenue from Operations
*******
 0.02%
*******
*******
*******
*******
Total Assets
*******
 11.74%
*******
*******
*******
*******
Profit or Loss
*******
 55.49%
*******
*******
*******
*******
Net Worth
*******
 -84.43%
*******
*******
*******
*******
EBITDA
*******
 -243.48%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Avizen Biopharma?

In 2024, Avizen Biopharma had a promoter holding of 76.32% and a public holding of 23.68%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹61,020,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 6.10 Cr
Latest Charge Details
Date Lender Amount Status
04 Dec 2021 Others ₹1.85 M Open
29 Sep 2020 Others ₹3.68 M Open
30 Mar 2017 Others ₹5.55 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Avizen Biopharma?

Avizen Biopharma has a workforce of 13 employees as of Feb 17, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Avizen Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avizen Biopharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Avizen Biopharma
Recent Activity within the Organization
  • Charges

    The activity A charge with Others of Rs. 5.55 Cr registered on 30 Mar 2017 with Charge ID 100094089 was modified on 14 Aug 2025. was completed.

  • Director Appointment

    The activity Alka Verma was appointed as a Director was appointed as a Director on 17 Jul 2025 & has been associated with this company since 7 months 3 days . was completed.

  • Annual General Meeting

    The activity Avizen Biopharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Avizen Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Guwahati. was documented.

  • Charges

    Progress on A charge with Others amounted to Rs. 0.19 Cr with Charge ID 100516420 was registered on 04 Dec 2021. was documented.

  • Charges

    A charge with Others amounted to Rs. 0.37 Cr with Charge ID 100397271 was registered on 29 Sep 2020. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Avizen Biopharma Private Limited?

The CIN of Avizen Biopharma Private Limited is U24304AS2016PTC017532.

Where is Avizen Biopharma Private Limited headquartered?

Avizen Biopharma Private Limited is headquartered at Sagar Bizz Plex, 1St Floor S.R. Bora Lane, G.S. Road, Ulubari, Guwahati, Assam, 781007.

When was Avizen Biopharma Private Limited incorporated?

Avizen Biopharma Private Limited was incorporated on 09 August 2016.

Who are the current directors of Avizen Biopharma Private Limited?

The current directors of Avizen Biopharma Private Limited are

What is the primary industry of Avizen Biopharma Private Limited?

The primary industry of Avizen Biopharma Private Limited is Manufacturing.

Is Avizen Biopharma Private Limited a listed company?

Avizen Biopharma Private Limited is unlisted.

What is the capital structure of Avizen Biopharma Private Limited?

The authorized capital of Avizen Biopharma Private Limited is ₹5.50 Cr, and the paid-up capital is ₹5.42 Cr.

What is the compliance status of Avizen Biopharma Private Limited?

The compliance status of Avizen Biopharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available